Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 730)
Posted On: 03/11/2024 9:44:34 AM
Post# of 154896
Posted By: KenChowder
Re: ohm20 #141743
Ohm wrote,
Quote:
Then only allowing two doses in four weeks that screwed up our trial. That damn sure is the FDA's fault



Forgive the recap. Most of you here remember (but perhaps not everyone: thus this note) exactly what Ohm is referring here.

In the CD12 trial of Leronlimab vs. Covid, FDA allowed only two weekly doses instead of the four Cytodyn wanted, and then compounded that mistake by insisting that the trial length be 28 days instead of the 14 Cytodyn wanted.

Leron's survival rate against Covid at 14 days, after the two weekly doses, was 82% higher than the placebo arm's. Two weeks later, after two weeks of no (fricking) treatment, the survival rate had reverted to something similar to the placebo arm's.

In other words, Leron could probably have allowed us to avert four out of every five Covid deaths. The results were right there, but without statistical significance re the primary endpoint, the FDA chose to say, out loud, and in public, that Leronlimab had demonstrated no efficacy in any trial. Murder most foul.

Sorry. I have to say that every once in a while. Will never get over it.













(26)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site